Errata: Follicular lymphoma: Evolving therapeutic strategies (Blood (2016) 127, 17, (2055-2063))

B. S. Kahl; D. T. Yang

doi:10.1182/blood-2016-06-721902

Errata: Follicular lymphoma: Evolving therapeutic strategies (Blood (2016) 127, 17, (2055-2063))

B. S. Kahl, D. T. Yang

Research output: Contribution to journal › Comment/debate

3 Scopus citations

Abstract

On page 2060 in the 28 April 2016 issue, there is an omission in Table 2. In column 2, the information for duvelisib (IPI-145), "PI3K-δ inhibitor," should read "PI3K-δ and PI3K-γ inhibitor." The corrected Table 2 is shown below. The error has been corrected in the online version, which now differs from the print version.

Original language	English
Pages (from-to)	463
Number of pages	1
Journal	Blood
Volume	128
Issue number	3
DOIs	https://doi.org/10.1182/blood-2016-06-721902
State	Published - Jul 21 2016

Access to Document

10.1182/blood-2016-06-721902

Cite this

@article{275364d5d9514686b37b99c52cd7e487,

title = "Errata: Follicular lymphoma: Evolving therapeutic strategies (Blood (2016) 127, 17, (2055-2063))",

abstract = "On page 2060 in the 28 April 2016 issue, there is an omission in Table 2. In column 2, the information for duvelisib (IPI-145), {"}PI3K-δ inhibitor,{"} should read {"}PI3K-δ and PI3K-γ inhibitor.{"} The corrected Table 2 is shown below. The error has been corrected in the online version, which now differs from the print version.",

author = "Kahl, \{B. S.\} and Yang, \{D. T.\}",

note = "Publisher Copyright: {\textcopyright} 2016 by The American Society of Hematology.",

year = "2016",

month = jul,

day = "21",

doi = "10.1182/blood-2016-06-721902",

language = "English",

volume = "128",

pages = "463",

journal = "Blood",

issn = "0006-4971",

number = "3",

}

TY - JOUR

T1 - Errata

T2 - Follicular lymphoma: Evolving therapeutic strategies (Blood (2016) 127, 17, (2055-2063))

AU - Kahl, B. S.

AU - Yang, D. T.

PY - 2016/7/21

Y1 - 2016/7/21

N2 - On page 2060 in the 28 April 2016 issue, there is an omission in Table 2. In column 2, the information for duvelisib (IPI-145), "PI3K-δ inhibitor," should read "PI3K-δ and PI3K-γ inhibitor." The corrected Table 2 is shown below. The error has been corrected in the online version, which now differs from the print version.

AB - On page 2060 in the 28 April 2016 issue, there is an omission in Table 2. In column 2, the information for duvelisib (IPI-145), "PI3K-δ inhibitor," should read "PI3K-δ and PI3K-γ inhibitor." The corrected Table 2 is shown below. The error has been corrected in the online version, which now differs from the print version.

UR - https://www.scopus.com/pages/publications/84979298690

U2 - 10.1182/blood-2016-06-721902

DO - 10.1182/blood-2016-06-721902

M3 - Comment/debate

C2 - 31659365

AN - SCOPUS:84979298690

SN - 0006-4971

VL - 128

SP - 463

JO - Blood

JF - Blood

IS - 3

ER -

Errata: Follicular lymphoma: Evolving therapeutic strategies (Blood (2016) 127, 17, (2055-2063))

Abstract

Access to Document

Other files and links

Fingerprint

Cite this